These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. Luo J; Tang M; Huang J; He BC; Gao JL; Chen L; Zuo GW; Zhang W; Luo Q; Shi Q; Zhang BQ; Bi Y; Luo X; Jiang W; Su Y; Shen J; Kim SH; Huang E; Gao Y; Zhou JZ; Yang K; Luu HH; Pan X; Haydon RC; Deng ZL; He TC J Biol Chem; 2010 Sep; 285(38):29588-98. PubMed ID: 20628059 [TBL] [Abstract][Full Text] [Related]
32. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling. Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928 [TBL] [Abstract][Full Text] [Related]
33. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. David L; Mallet C; Keramidas M; Lamandé N; Gasc JM; Dupuis-Girod S; Plauchu H; Feige JJ; Bailly S Circ Res; 2008 Apr; 102(8):914-22. PubMed ID: 18309101 [TBL] [Abstract][Full Text] [Related]
34. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting. van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445 [TBL] [Abstract][Full Text] [Related]
35. Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic Fibrosis. Desroches-Castan A; Tillet E; Ricard N; Ouarné M; Mallet C; Belmudes L; Couté Y; Boillot O; Scoazec JY; Bailly S; Feige JJ Hepatology; 2019 Oct; 70(4):1392-1408. PubMed ID: 30964206 [TBL] [Abstract][Full Text] [Related]
36. Bone morphogenetic protein‑9 promotes the differentiation of mouse spleen macrophages into osteoclasts via the ALK1 receptor and ERK 1/2 pathways in vitro. Li H; Zhao D; Wang S; Ding J; Zhao L Mol Med Rep; 2016 Nov; 14(5):4545-4550. PubMed ID: 27748860 [TBL] [Abstract][Full Text] [Related]
37. ALK1 signaling is required for the homeostasis of Kupffer cells and prevention of bacterial infection. Zhao D; Yang F; Wang Y; Li S; Li Y; Hou F; Yang W; Liu D; Tao Y; Li Q; Wang J; He F; Tang L J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34874921 [TBL] [Abstract][Full Text] [Related]
38. Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis. Owen NE; Alexander GJ; Sen S; Bunclark K; Polwarth G; Pepke-Zaba J; Davenport AP; Morrell NW; Upton PD EBioMedicine; 2020 Jun; 56():102794. PubMed ID: 32454407 [TBL] [Abstract][Full Text] [Related]
39. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models. Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244 [TBL] [Abstract][Full Text] [Related]
40. Circulating Bmp10 acts through endothelial Alk1 to mediate flow-dependent arterial quiescence. Laux DW; Young S; Donovan JP; Mansfield CJ; Upton PD; Roman BL Development; 2013 Aug; 140(16):3403-12. PubMed ID: 23863480 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]